FTG.TO vs. RXRX
Compare and contrast key facts about Firan Technology Group Corporation (FTG.TO) and Recursion Pharmaceuticals, Inc. (RXRX).
Performance
FTG.TO vs. RXRX - Performance Comparison
Loading graphics...
FTG.TO vs. RXRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
FTG.TO Firan Technology Group Corporation | 61.30% | 58.44% | 71.53% | 80.85% | -11.32% | 14.22% |
RXRX Recursion Pharmaceuticals, Inc. | -23.92% | -42.27% | -25.55% | 25.07% | -51.78% | -44.68% |
Different Trading Currencies
FTG.TO is traded in CAD, while RXRX is traded in USD. To make them comparable, the RXRX values have been converted to CAD using the latest available exchange rates.
Fundamentals
FTG.TO:
CA$468.98M
RXRX:
$1.62B
FTG.TO:
CA$0.52
RXRX:
-$1.39
FTG.TO:
2.52
RXRX:
19.09
FTG.TO:
4.86
RXRX:
1.43
FTG.TO:
CA$187.37M
RXRX:
$74.56M
FTG.TO:
CA$57.66M
RXRX:
$3.73M
FTG.TO:
CA$28.64M
RXRX:
-$579.69M
Returns By Period
In the year-to-date period, FTG.TO achieves a 61.30% return, which is significantly higher than RXRX's -23.92% return.
FTG.TO
- 1D
- 6.09%
- 1M
- -13.63%
- YTD
- 61.30%
- 6M
- 57.75%
- 1Y
- 150.40%
- 3Y*
- 84.63%
- 5Y*
- 54.59%
- 10Y*
- 23.76%
RXRX
- 1D
- 7.98%
- 1M
- -14.70%
- YTD
- -23.92%
- 6M
- -37.15%
- 1Y
- -43.90%
- 3Y*
- -22.05%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FTG.TO vs. RXRX — Risk / Return Rank
FTG.TO
RXRX
FTG.TO vs. RXRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Firan Technology Group Corporation (FTG.TO) and Recursion Pharmaceuticals, Inc. (RXRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.27 | -0.53 | +3.80 |
Sortino ratioReturn per unit of downside risk | 3.74 | -0.45 | +4.20 |
Omega ratioGain probability vs. loss probability | 1.45 | 0.95 | +0.50 |
Calmar ratioReturn relative to maximum drawdown | 6.43 | -0.83 | +7.26 |
Martin ratioReturn relative to average drawdown | 15.67 | -1.64 | +17.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.27 | -0.53 | +3.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.32 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.54 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.05 | -0.39 | +0.34 |
Correlation
The correlation between FTG.TO and RXRX is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
FTG.TO vs. RXRX - Dividend Comparison
Neither FTG.TO nor RXRX has paid dividends to shareholders.
Drawdowns
FTG.TO vs. RXRX - Drawdown Comparison
The maximum FTG.TO drawdown since its inception was -99.96%, which is greater than RXRX's maximum drawdown of -92.35%. Use the drawdown chart below to compare losses from any high point for FTG.TO and RXRX.
Loading graphics...
Drawdown Indicators
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.96% | -93.13% | -6.83% |
Max Drawdown (1Y)Largest decline over 1 year | -22.58% | -58.17% | +35.59% |
Max Drawdown (5Y)Largest decline over 5 years | -47.21% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -68.78% | — | — |
Current DrawdownCurrent decline from peak | -95.95% | -92.57% | -3.38% |
Average DrawdownAverage peak-to-trough decline | -91.05% | -74.76% | -16.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.26% | 29.28% | -20.02% |
Volatility
FTG.TO vs. RXRX - Volatility Comparison
Firan Technology Group Corporation (FTG.TO) has a higher volatility of 16.64% compared to Recursion Pharmaceuticals, Inc. (RXRX) at 14.76%. This indicates that FTG.TO's price experiences larger fluctuations and is considered to be riskier than RXRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FTG.TO | RXRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.64% | 14.76% | +1.88% |
Volatility (6M)Calculated over the trailing 6-month period | 35.56% | 54.63% | -19.07% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.30% | 83.79% | -37.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.04% | 93.63% | -51.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 44.81% | 93.63% | -48.82% |
Financials
FTG.TO vs. RXRX - Financials Comparison
This section allows you to compare key financial metrics between Firan Technology Group Corporation and Recursion Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities